John Corl, MD
Interventional Cardiology · Cincinnati, OHNPI 1790778595
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Shockwave Medical, Inc accounts for 62.3% of it on its own, with 35 other manufacturers making up the rest. 2025 is the largest year on record at $144,553, more than ten times the $9,024 reported in 2019. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 561 payments — averaging $694.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$243K
- Abbott$109K
- Cardinal Health 200 LLC$6K
- Boston Scientific$6K
- Endologix LLC$6K
- Cardiovascular Systems Inc.$5K
- plus $15K from 30 others
Across 129 payments — averaging $3124.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$190K
- Medtronic$102K
- Abbott$62K
- Endologix LLC$33K
- Terumo Medical Corporation$17K
What the payments were for
- Consulting fees$204,86853%
- Speaking & faculty fees$109,91528%
- Travel & lodging$49,69013%
- Food & beverage$25,1236%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 201 | $242,650 |
| Abbott | 109 | $109,141 |
| Cardinal Health 200 LLC | 41 | $6,389 |
| Boston Scientific | 20 | $5,722 |
| Endologix LLC | 17 | $5,594 |
| Cardiovascular Systems Inc. | 7 | $5,187 |
| Medtronic(2 entities) | 59 | $4,724 |
| Cordis US CORP. | 9 | $3,485 |
| Reflow Medical Inc | 18 | $3,063 |
| Inari Medical, Inc. | 5 | $630 |
| Limflow Inc. | 2 | $614 |
| Philips North America LLC | 7 | $564 |
| Biotronik Inc. | 16 | $259 |
| Novartis | 6 | $182 |
| Amgen | 6 | $182 |
| AstraZeneca | 8 | $182 |
| Cook Medical LLC | 2 | $168 |
| Penumbra, Inc. | 1 | $152 |
| Surmodics, Inc. | 1 | $142 |
| Johnson & Johnson | 8 | $125 |
| KCI USA, Inc. | 1 | $108 |
| Imperative Care, Inc | 2 | $100 |
| Abiomed | 1 | $97 |
| AbbVie | 1 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Edwards Lifesciences | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Cleerly, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Truvic Medical, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$234,898
- Perclose ProStyle$25,163
- Dragonfly OCT$23,750
- ESPRIT$21,206
- PROSTAR$16,500
- JETi Peripheral Catheter$8,804
- Vascular Lithotripsy$5,933
- AngioJet XMI$4,500
- Peripheral Orbital Atherectomy System$3,300
- XIENCE SKYPOINT$3,025
- Torus Stent Graft System$2,691
- ENDOCROSS Device$2,691
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,500
- PERCLOSE PROGLIDE$1,963
- BRITE TIP$1,900
- SUPERA$1,744
- Diamondback Peripheral$1,680
- IN.PACT Admiral$1,099
- Resolute$1,011
- SYMPLICITY G3$801
How this compares
$389,690 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 115 | $122,690 |
| XareltoRivaroxaban | 47 | $49,211 |
| Repatha SureclickEvolocumab | 12 | $12,354 |
| Metoprolol Succinate | 164 | $1,877 |
| Rosuvastatin Calcium | 105 | $1,818 |
| Ranolazine ErRanolazine | 23 | $1,305 |
| Atorvastatin Calcium | 112 | $1,091 |
| Carvedilol | 99 | $843 |
| Amlodipine Besylate | 146 | $822 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 30 | $756 |
| ClopidogrelClopidogrel Bisulfate | 57 | $580 |
| Valsartan | 19 | $575 |
| Losartan Potassium | 73 | $463 |
| Potassium Chloride | 27 | $403 |
| Pravastatin Sodium | 24 | $398 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $125 | $49,21147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Cincinnati
- Timothy HenryCincinnati$605K
- Santiago GarciaCincinnati$360K
- Joseph ChooCincinnati$224K
- Dean KereiakesCincinnati$139K
- Ian SarembockCincinnati$98K
- Puvi SeshiahCincinnati$81K
- Raviteja GuddetiCincinnati$68K
- Satya ShreenivasCincinnati$47K
- Amer SayedCincinnati$31K
- Zaid AlirhayimCincinnati$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.